ロード中...
The predictive significance of CD20 expression in B-cell lymphomas
BACKGROUND: In our recent study, we determined the cut-off value of CD20 expression at the level of 25 000 molecules of equivalent soluble fluorochrome (MESF) to be the predictor of response to rituximab containing treatment in patients with B-cell lymphomas. In 17.5% of patients, who had the level...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3083324/ https://ncbi.nlm.nih.gov/pubmed/21486448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-6-33 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|